“Treat MS properly at the start and we may be able to delay or prevent the secondary progressive phase.”
The outlook for people with multiple sclerosis (MS) looks likely to improve. That was the message from Professor Gavin Giovannoni as he addressed over 400 delegates at the MS Trust Conference in Windsor, UK. In his talk, ‘Looking to the future’, Professor Giovannoni summarized clinical trial results for products at different stages of development and presented the therapeutic strategy outlined in Brain health: time matters in multiple sclerosis.
Highlighting the importance of early diagnosis and treatment initiation, Professor Giovannoni proposed a future where we “stop people with MS becoming disabled in the first place”. He told fellow healthcare professionals: “treat MS properly at the start and we may be able to delay or prevent the secondary progressive phase”. Professor Giovannoni also emphasized the need for a clear treatment goal, regular monitoring of patients using MRI and timely switching of therapies when disease control is suboptimal to preserve brain health.
Delegates included MS specialist nurses, physiotherapists and researchers, and every delegate received a four-page summary of the policy recommendations. Professor Giovannoni urged the audience, and anyone who wants to improve the lives of people with MS, to pledge their support here.